Northeast Tiger Pharmaceutical Co. Ltd. provided earnings guidance for the year ended December 31, 2014. For the period, the company may record a significant decrease in net profit and will record loss as compared to that of the corresponding period in 2013.
1st Jan change | Capi. | |
---|---|---|
+32.48% | 5.8B | |
-26.22% | 3.92B | |
+4.73% | 3.28B | |
-20.86% | 2.77B | |
-11.88% | 2.26B | |
+46.64% | 1.95B | |
-16.71% | 1.52B | |
+44.65% | 1.49B | |
-9.60% | 1.49B |